logologo
QuantliQuantli

Nurix Therapeutics Inc

NRIX

NASDAQ

Biotechnology

$27.05

USD

-0.14 (-0.51%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $2.79B

Volume 738.2K

Price Target

$25.00$45.00

USD

The 8 analysts offering 1-year price forecasts have a max estimate of $45.00 and a min estimate of $25.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$33.63

+$5.0 vs prior

Implied Upside

+24.3%

+18.3% vs prior

Analyst Covering

8

+5 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

73%

Most ratings are recent - from the last 3 months

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$0.1300 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

8 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

8

Hold

0

Sell

0

Strong Sell

0

8 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Joseph Catanzaro

Piper Sandler

Buy

Maintained

4 weeks ago

Plus
Plus
Plus

Robert Burns

HC Wainwright & Co.

Buy

Maintained

1 month ago

Plus
Plus
Plus

Gil Blum

Needham

Buy

Reiterated

1 month ago

Plus
Plus
Plus

Jeet Mukherjee

BTIG

Buy

Reiterated

1 month ago

Plus
Plus
Plus

Joel Beatty

Baird

Buy

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

BEAM

Beam Therapeutics Inc

$26.75

+0.9%

GRAL

Grail Inc

$67.87

-0.5%

IOVA

Iovance Biotherapeutics Inc

$6.98

+7.1%

SLS

Sellas Life Sciences Group Inc

$12.78

+3.4%

COAG

Hemab Therapeutics Holdings Inc

$54.94

+1.8%

KOD

Kodiak Sciences Inc

$41.35

+3.4%

IMNM

Immunome Inc

$27.20

+3.0%

IRON

Disc Medicine Inc

$78.84

-1.5%

RARE

Ultragenyx Pharmaceutical Inc

$26.49

+0.4%